Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of bioactive molecules and drug candidates. Its structure supports the creation of complex organic compounds due to the electron-withdrawing trifluoromethyl group, which enhances metabolic stability and lipophilicity in medicinal chemistry. Commonly employed in the preparation of chiral building blocks for asymmetric synthesis. Also utilized in agrochemicals for designing active ingredients with improved environmental stability and efficacy. The compound's ring strain and functional group positioning make it valuable in ring-expansion and cyclization reactions for novel heterocycle formation.